The Scientist

» liver disease

Most Recent

image: Allergan’s Buying Spree Rolls On

Allergan’s Buying Spree Rolls On

By | September 21, 2016

The Ireland-based pharma company makes a $1.7 billion offer to acquire Tobira Therapeutics, a US firm developing liver disease drugs.

0 Comments

image: Improving Gene Therapy with In Vivo Selection

Improving Gene Therapy with In Vivo Selection

By | June 8, 2016

Scientists have developed a way to selectively expand genetically modified hepatocytes in mice.

0 Comments

image: Triglyceride Clock

Triglyceride Clock

By | February 10, 2014

The timing of meals affects the levels of lipids in the livers of mice, according to a study.

0 Comments

image: Obesity-Cancer Link Detailed

Obesity-Cancer Link Detailed

By | June 26, 2013

Obesity drives an alteration of the gut microbiome, leading to the secretion of metabolites associated with the development of liver cancer.

2 Comments

image: Synthetic Spirits

Synthetic Spirits

By | January 1, 2011

Can we use science to reduce the harms of alcohol?

0 Comments

Popular Now

  1. Consilience, Episode 3: Cancer, Obscured
  2. RNAi’s Future in Drug-Target Screening
    News Analysis RNAi’s Future in Drug-Target Screening

    A recent CRISPR study contradicted years of RNA interference research on a well-studied cancer drug target. But is it the last nail in the coffin for RNAi as a screening tool? 

  3. A History of Screening for Natural Products to Fight Cancer
  4. Human Cord Plasma Protein Boosts Cognitive Function in Older Mice
AAAS